SAN DIEGO, Oct. 29, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and ...

Pfizer Inc (NYSE:PFE) reported better-than-expected fourth quarter 2025 earnings on February 3, 2026, with adjusted diluted EPS of $0.66 exceeding analyst expectations of $0.58 by 13.79%. Despite the ...

Obesity now affects more than one in five children in the United States, and while there are effective, recommended interventions, availability is limited for most children. In two new studies, Yale ...

Ladies and gentlemen, thank you for standing by. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to Helen Rubinstein, ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced ...

Clemson University has received $768,000 in funding from the Centers for Disease Control and Prevention to implement the first year of $3.8 million, five-year High Obesity Program in rural and ...

Paul L. Berns, Chief Executive Officer, stated that Neumora "prioritized obesity as the lead indication for NMRA-215, our highly brain-penetrant NLRP3 inhibitor." He outlined, "We expect to have up to ...